14. Will FDA take action against cannabis or cannabis-related products that are in violation of the FD&C Act?
10. Is it legal, in interstate commerce, to sell a food (including any animal food or feed) to which THC or CBD has been added?
3. Has FDA approved any medical products containing cannabis or cannabis-derived compounds such as CBD?
Questions and Answers
23. What should I do if my child eats something containing cannabis?
Conducting clinical research using cannabis-related substances that are scheduled by the DEA often involves interactions with several federal agencies. This includes: a registration administered by the DEA; obtaining the cannabis for research from NIDA, within the National Institutes of Health, or another DEA-registered source; and review by the FDA of the IND or INAD application and research protocol. Additionally:
A. Cannabis is a plant of the Cannabaceae family and contains more than eighty biologically active chemical compounds. The most commonly known compounds are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Parts of the Cannabis sativa plant have been controlled under the Controlled Substances Act (CSA) since 1970 under the drug class “Marihuana” (commonly referred to as “marijuana”) [21 U.S.C. 802(16)]. “Marihuana” is listed in Schedule I of the CSA due to its high potential for abuse, which is attributable in large part to the psychoactive effects of THC, and the absence of a currently accepted medical use of the plant in the United States.
A. Information for patients on Right to Try (RTT) is available on our website. RTT is designed to facilitate access to certain investigational drugs through direct interactions between patients, their physicians and drug sponsors – FDA is not involved in these decisions. Sponsors developing drugs for life-threatening conditions are responsible for determining whether to make their products available to patients who qualify for access under RTT. If you are interested in RTT, you should discuss this pathway with your licensed physician. Companies who develop drugs and biologics, also known as sponsors, can provide information about whether their drug/biologic is considered an eligible investigational drug under RTT and if they are able to provide the drug/biologic under the RTT Act.
Licensed farmers can now grow the plant, as long as it contains less than 0.3% THC. The result? CBD is turning up in everything from oils and lotions to coffee and cookies.
A 2017 study found that about seven out of 10 CBD products did not contain the amount of cannabidiol stated on the label. And about one in five contained THC.
What should you do if you use any of these products and have a drug test coming up?
She and her colleagues at the University of Utah Health Sciences Center in Salt Lake City spiked three batches of urine samples with CBD, CBN and two other cannabis compounds — cannabichromene and cannabigerol.
The researchers tested each batch with two tests commonly used for THC screening. CBN reacted with one, while the other three compounds triggered no false-positives.
So for these consumers, the question inevitably arises: Do CBD products contain THC?
CBD has the potential to mitigate the intoxicating and potentially adverse effects of THC, while THC may contribute to or enhance the therapeutic effects of CBD. Photo by: Gina Coleman/Weedmaps
Be careful about which direction the ratio goes though. Cannabis high in THC and low in CBD may be even more intoxicating than THC alone, according to an Australianstudy.
First, CBD can be derived from hemp or from cannabis. If it’s from hemp, there can’t be any more than 0.3% THC in it, by law. That’s the CBD that you should be able to purchase in just about any US state because hemp is legal across the land. (Sorry, Idahoans, this doesn’t apply to you.) CBD that’s been extracted from marijuana, on the other hand, could have any amount of THC in it and is only available in states where medical and/or recreational cannabis is legal. In medical states, you’ll need to be a registered patient to participate.
Next, pay attention to whether a CBD product is full-spectrum, broad-spectrum, or isolate.